218 related articles for article (PubMed ID: 25666181)
1. A ligand-observed mass spectrometry approach integrated into the fragment based lead discovery pipeline.
Chen X; Qin S; Chen S; Li J; Li L; Wang Z; Wang Q; Lin J; Yang C; Shui W
Sci Rep; 2015 Feb; 5():8361. PubMed ID: 25666181
[TBL] [Abstract][Full Text] [Related]
2. Multiple ligand detection and affinity measurement by ultrafiltration and mass spectrometry analysis applied to fragment mixture screening.
Qin S; Ren Y; Fu X; Shen J; Chen X; Wang Q; Bi X; Liu W; Li L; Liang G; Yang C; Shui W
Anal Chim Acta; 2015 Jul; 886():98-106. PubMed ID: 26320641
[TBL] [Abstract][Full Text] [Related]
3. Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.
Antonysamy SS; Aubol B; Blaney J; Browner MF; Giannetti AM; Harris SF; Hébert N; Hendle J; Hopkins S; Jefferson E; Kissinger C; Leveque V; Marciano D; McGee E; Nájera I; Nolan B; Tomimoto M; Torres E; Wright T
Bioorg Med Chem Lett; 2008 May; 18(9):2990-5. PubMed ID: 18400495
[TBL] [Abstract][Full Text] [Related]
4. Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.
Zhang HX; Li Y; Wang X; Xiao ZT; Wang YH
Curr Med Chem; 2011; 18(26):4019-28. PubMed ID: 21824089
[TBL] [Abstract][Full Text] [Related]
5. Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development.
Barreca ML; Iraci N; Manfroni G; Cecchetti V
Future Med Chem; 2011 Jun; 3(8):1027-55. PubMed ID: 21707403
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry for fragment screening.
Chan DS; Whitehouse AJ; Coyne AG; Abell C
Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
[TBL] [Abstract][Full Text] [Related]
7. Native Mass Spectrometry in Fragment-Based Drug Discovery.
Pedro L; Quinn RJ
Molecules; 2016 Jul; 21(8):. PubMed ID: 27483215
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.
Yeung KS; Beno BR; Parcella K; Bender JA; Grant-Young KA; Nickel A; Gunaga P; Anjanappa P; Bora RO; Selvakumar K; Rigat K; Wang YK; Liu M; Lemm J; Mosure K; Sheriff S; Wan C; Witmer M; Kish K; Hanumegowda U; Zhuo X; Shu YZ; Parker D; Haskell R; Ng A; Gao Q; Colston E; Raybon J; Grasela DM; Santone K; Gao M; Meanwell NA; Sinz M; Soars MG; Knipe JO; Roberts SB; Kadow JF
J Med Chem; 2017 May; 60(10):4369-4385. PubMed ID: 28430437
[TBL] [Abstract][Full Text] [Related]
9. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections.
Beaulieu PL; Tsantrizos YS
Curr Opin Investig Drugs; 2004 Aug; 5(8):838-50. PubMed ID: 15600240
[TBL] [Abstract][Full Text] [Related]
11. Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study.
Schiebel J; Radeva N; Krimmer SG; Wang X; Stieler M; Ehrmann FR; Fu K; Metz A; Huschmann FU; Weiss MS; Mueller U; Heine A; Klebe G
ACS Chem Biol; 2016 Jun; 11(6):1693-701. PubMed ID: 27028906
[TBL] [Abstract][Full Text] [Related]
12. Rational Drug Discovery of HCV Helicase Inhibitor: Improved Docking Accuracy with Multiple Seeding in AutoDock Vina and In Situ Minimization.
Lim SK; Othman R; Yusof R; Heh CH
Curr Comput Aided Drug Des; 2017; 13(2):160-169. PubMed ID: 27903217
[TBL] [Abstract][Full Text] [Related]
13. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
14. Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.
De Francesco R; Carfí A
Adv Drug Deliv Rev; 2007 Oct; 59(12):1242-62. PubMed ID: 17869377
[TBL] [Abstract][Full Text] [Related]
15. Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
Therese PJ; Manvar D; Kondepudi S; Battu MB; Sriram D; Basu A; Yogeeswari P; Kaushik-Basu N
J Chem Inf Model; 2014 Feb; 54(2):539-52. PubMed ID: 24460140
[TBL] [Abstract][Full Text] [Related]
16. The discovery of finger loop inhibitors of the hepatitis C virus NS5B polymerase: status and prospects for novel HCV therapeutics.
Beaulieu PL
IDrugs; 2006 Jan; 9(1):39-43. PubMed ID: 16374732
[TBL] [Abstract][Full Text] [Related]
17. Accounting for target flexibility and water molecules by docking to ensembles of target structures: the HCV NS5B palm site I inhibitors case study.
Barreca ML; Iraci N; Manfroni G; Gaetani R; Guercini C; Sabatini S; Tabarrini O; Cecchetti V
J Chem Inf Model; 2014 Feb; 54(2):481-97. PubMed ID: 23952658
[TBL] [Abstract][Full Text] [Related]
18. Interactions of the Disordered Domain II of Hepatitis C Virus NS5A with Cyclophilin A, NS5B, and Viral RNA Show Extensive Overlap.
Ngure M; Issur M; Shkriabai N; Liu HW; Cosa G; Kvaratskhelia M; Götte M
ACS Infect Dis; 2016 Nov; 2(11):839-851. PubMed ID: 27676132
[TBL] [Abstract][Full Text] [Related]
19. Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors.
Musmuca I; Caroli A; Mai A; Kaushik-Basu N; Arora P; Ragno R
J Chem Inf Model; 2010 Apr; 50(4):662-76. PubMed ID: 20225870
[TBL] [Abstract][Full Text] [Related]
20. Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.
Silvestre HL; Blundell TL; Abell C; Ciulli A
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):12984-9. PubMed ID: 23872845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
